Regulation of ATP production by mitochondrial Ca(2+).

Tarasov AI, Griffiths EJ, Rutter GA. · 2012

Read Regulation of ATP production by mitochondrial Ca(2+). by Tarasov AI, Griffiths EJ, Rutter GA. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3396849.txt.

Introduction

Tarasov, Griffiths, and Rutter reviewed in 2012 how calcium inside mitochondria controls production of ATP, the cell's energy currency. It is now widely accepted that calcium switches mitochondrial burning into a higher gear. The review explains the machinery that links the two.

Heart muscle cells and insulin-making pancreas cells get special attention, because both must answer sudden changes: a harder workload in the heart, a meal in the pancreas. Keeping ATP matched to demand is central in both. The authors also present a fresh way to film ATP levels changing in single living cells as calcium acts. The method promises direct views of energy control at work.

Catalog record

CREATORTarasov AI, Griffiths EJ, Rutter GA.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3396849

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Regulation of ATP production by mitochondrial Ca2+ By Andrei I. Tarasov, Elinor J. Griffiths, Guy A. Rutter Published in: Cell Calcium DOI: 10.1016/j.ceca.2012.03.003 ABSTRACT Stimulation of mitochondrial oxidative metabolism by Ca2+ is now generally recognised as important for the control of cellular ATP homeostasis. Here, we review the mechanisms through which Ca2+ regulates mitochondrial ATP synthesis. We focus on cardiac myocytes and pancreatic β-cells, where tight control of this process is likely to play an important role in the response to rapid changes in workload and to nutrient stimulation, respectively. We also describe a novel approach for imaging the Ca2+-dependent regulation of ATP levels dynamically in single cells. INTRODUCTION Mitochondria are the major site of oxidative metabolism, and hence ATP synthesis, in eukaryotic cells. Thus, whereas the glycolytic metabolism of glucose generates 2 ATP molecules, 36–38 are generated by the reactions of the citrate cycle and the oxidation of the resulting NADH and FADH2 by the respiratory chain [1]. The latter reactions are tightly controlled by intramitochondrial Ca2+ in a mechanism designed to ensure that ATP synthesis is closely coupled to the cell's energetic needs. We discuss this form of regulation in detail here, taking as examples two cell types with contrasting energetic needs, the cardiac myocyte and the pancreatic β cell. CA2+ REGULATION OF INTRAMITOCHONDRIAL OXIDATIVE METABOLISM: A BRIEF HISTORICAL PERSPECTIVE Mitochondrial oxidative metabolism has long been recognised as subject to complex regulation by several factors, notably the concentrations of ADP and substrate(s) [2]. However, regulation by Ca2+ has emerged in recent years as a further important means of controlling this vital aspect of cell function. Mammalian mitochondria have a huge capacity for Ca2+ uptake and for many years it was thought that these organelles served as mobilisable intracellular reservoirs of Ca2+ ions [3]. Studies in the 1970s and 80s by Denton and McCormack [4] as well as Hansford and Castro [5] and Crompton [6] indicated instead that under basal conditions total mitochondrial Ca2+ content was low and that increases in cytosolic free Ca2+ ([Ca2+]c) in response to extrinsic agents (nutrients, hormones, neurotransmitters, etc.), were likely to provoke increases in intramitochondrial free Ca2+ ([Ca2+]m) concentrations. Thus, based on the properties of a group of key intramitochondrial dehydrogenases (later characterised in some detail – see the following sections) [7,8], it was proposed that the uptake of Ca2+ ions from the cytosol increased [Ca2+]m from ∼0.1 to 10 μM or more. The consequent activation of oxidative metabolism would then provide an increased supply of reducing equivalents to drive respiratory chain activity and ATP synthesis. Export of mitochondrial ATP in exchange for ADP was anticipated then to meet an increased ATP demand to fuel energy-requiring processes in the cytosol such as ion pumping, contraction, exocytosis etc. The biochemical analyses (e.g. [9]) upon which the above model was based were subsequently complemented and reinforced in the 1990s by highly selective measurements of intramitochondrial free Ca2+ in living cells by Rizzuto, Pozzan, Rutter and others [10,11]. These experiments used recombinant expression of the Ca2+-sensitive photoprotein aequorin, targeted to the mitochondrial matrix by in-frame fusion with the signal peptide of cytochrome c subunit VIII. Later extended by Rutter et al. to measurements at the level of single cells [12], this approach provided evidence that basal intramitochondrial Ca2+ levels were indeed low (similar to or lower than those in the cytosol, i.e. ≤100 nM) and that the free concentrations of the ion increased within mitochondria in response to Ca2+-mobilising agonists. Subsequent refinements of these approaches, including the use of GFP-based probes, highlighted the importance of close contacts between the endoplasmic reticulum and mitochondria in the uptake of Ca2+ by the latter [13] and demonstrated that mitochondrial Ca2+ increases stably elevate mitochondrial [ATP] [14]. MITOCHONDRIAL CA2+ TRANSPORT: ROLES OF THE MITOCHONDRIAL UNIPORTER MCU AND THE NA+/CA2+ EXCHANGER, MNCX/NCLX An impediment to progress in this field has been that the mitochondrial Ca2+ transport proteins were not purified or cloned, and that use of the inhibitors of these pathways is problematic in living cells. However, recent work has very likely identified the proteins responsible for both the Ca2+ influx and Ca2+ efflux pathways in mitochondria (see below). Increases in [Ca2+]c are relayed to the mitochondria by the mitochondrial Ca2+ uniporter (MCU), resulting in activation of mitochondrial dehydrogenases and stimulation of ATP synthesis. Average [Ca2+]m is controlled by the activities of the MCU and the efflux pathway, the mitochondrial Na+/Ca2+ exchanger (mNCX). Ca2+ uptake is respiration-dependent, thus high rates of uptake can effectively lower the mitochondrial membrane potential (ΔΨm) (reviewed in [15]). This phenomenon can be observed clearly in isolated mitochondria at supraphysiological concentrations of extramitochondrial Ca2+; however, under physiological conditions of Ca2+ uptake, a change in ΔΨm has not been detected in isolated cardiomyocytes using fluorescent indicators. Thus, Ca2+ uptake would not normally be expected to lower the membrane potential, at least for a sustained period, or to such an extent that it would inhibit ATP synthesis. Nonetheless, transient and small decreases in mitochondrial membrane potential may occur during cytosolic Ca2+ peaks in other systems, and can be observed in pancreatic β cells by following rhodamine-123 accumulation [16] or sensitive fluorescent ATP probes (Tarasov and Rutter, unpublished and see below). The Ca2+ transport pathways of mitochondria are covered in more detail by other reviews in this issue. However, a brief discussion of their properties specifically with regard to energy production will be given here. Early studies on isolated mitochondria characterised the MCU as a low affinity, high capacity transporter of Ca2+, whereas the mNCX had a much lower Vmax, saturating at [Ca2+]m below 1 μM (reviewed in [17,15]). Thus, it was predicted that net Ca2+ influx would occur only when external [Ca2+] rose above about 500 nM, much higher than normal resting [Ca2+]c of 100–200 nM [18]. Studies in living adult rat myocytes [Ca2+]m confirmed this prediction, since [Ca2+]m remained less than [Ca2+]c until the latter rose above 500 nM [18]. However, the seminal paper by Rizzuto, Pozzan and colleagues in 1992, using aequorin targeted to mitochondria, revealed that these organelles were capable of taking up Ca2+ on a fast timescale, due to their proximity to intracellular Ca2+ stores [10] so they would effectively “see” much higher [Ca2+]c than that of the bulk cytosol. In some cells and species [Ca2+]m has been reported to change in response to physiological, submicromolar, changes in [Ca2+]c; but, in cardiomyocytes for example, the reflected changes in [Ca2+]m were small, 10–20 nM [19]. Research into the mitochondrial Ca2+ transporters is now likely to undergo another step change, with the identification of proteins corresponding to both MCU and mNCX. Two papers published simultaneously in 2011 identified a Ca2+ uptake pathway in mitochondria, inhibited by ruthenium red: Baughman et al. [20] identified the MCU as a novel predicted transmembrane protein (CCD109A) that formed oligomers in the inner membrane, and interacted with their previously identified regulator protein, MICU1. Silencing MCU in cultured cells or in vivo in mouse liver abrogated Ca2+ uptake, but membrane potential and respiration remain intact. A point mutation removed the sensitivity to ruthenium red (RuR). The other paper [21] identified MCU as a 40 kD protein with 2 transmembrane regions. RNA silencing of MCU in HeLa cells reduced mitochondrial Ca2+ uptake, and purified

Read the complete text